SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Catalyst Acquisition Corp. consummated a $200 million IPO on July 27, 2026, and entered into multiple material definitive agreements (Underwriting Agreement, Investment Management Trust Agreement, Private Placement Units Purchase Agreement, Administrative Services Agreement, and others) establishing the blank-check SPAC structure for future business combination activity.
View raw filing on EDGAR →Global Mofy AI Limited entered into a Share Exchange and Investment Agreement on July 29, 2026, to acquire a 2% equity interest in Star Touch (Beijing) Technology Co., Ltd. in exchange for issuing 2,500,000 Class A ordinary shares valued at US$2 million. This constitutes a material acquisition of equity interests in a target company engaged in AI solutions, which is strategically complementary to the Company's existing operations. The transaction structure, valuation, and regulatory filing requirements indicate a discrete M&A event material to investors.
View raw filing on EDGAR →MiMedx entered into a definitive Agreement and Plan of Merger to acquire all outstanding shares of Sanara MedTech for $35 per share in a cash-and-stock transaction valued at approximately $350 million enterprise value. The transaction, unanimously approved by both boards and backed by $300 million in committed debt financing, is expected to close by year-end 2026 subject to Sanara shareholder approval and regulatory clearance, and is described as a transformational combination that will nearly double surgical revenue.
View raw filing on EDGAR →Tiptree entered into a definitive Stock Purchase Agreement on July 28, 2026, to acquire 100% of Universal Shield Insurance Group (USIG) for $100 million in cash, with closing expected in Q1 2027 subject to regulatory approvals. This material acquisition represents a strategic re-establishment of Tiptree's specialty insurance footprint following recent divestitures.
View raw filing on EDGAR →AXT entered into a definitive Capacity Reservation Agreement with Lumentum on July 26, 2026, securing a six-year supply commitment for indium phosphide wafer substrates with two deposits totaling $87 million. While this is a supply/capacity agreement rather than a traditional M&A transaction, it represents a material long-term commercial arrangement that would significantly affect investor assessment of AXT's revenue visibility and strategic positioning. The substantial upfront deposits ($43.5M due within 30 days) and multi-year commitment structure make this a material definitive agreement under Item 1.01.
View raw filing on EDGAR →Accuray entered into a Securities Purchase Agreement with TCW Asset Management Company LLC involving issuance of 55,000 shares of Series A Convertible Preferred Stock for $55 million ($15 million cash plus $40 million debt conversion), cancellation of approximately 27.6 million warrants, and amendment of the Financing Agreement. The transaction includes board designation rights for TCW (2 of 7 directors), consent rights over major corporate actions, and conversion rights at $0.50 per share, fundamentally representing a material change of control and recapitalization.
View raw filing on EDGAR →Processa Pharmaceuticals completed a material merger with Vidya Therapeutics on July 28, 2026, acquiring Vidya's clinical-stage BTK inhibitor program (VT-7208) through a stock-for-stock transaction. Vidya shareholders received 558,398 shares of common stock and 142,744.100 shares of Series A Preferred Stock, with pre-transaction Processa shareholders diluted to approximately 0.9% post-transaction.
View raw filing on EDGAR →FOXO Technologies' subsidiary Vector BioSource has entered into a definitive agreement to acquire four U.S.-based blood collection centers from Grifols Bio Supplies, Inc. The filing explicitly states this is a material acquisition expected to add over $10 million in net revenues in the twelve months following closing. The transaction involves a purchase of assets with upfront cash payment and potential earnout provisions, structured as a material acquisition of operating assets that will expand Vector's business capabilities and market access through FDA licensure.
View raw filing on EDGAR →The filing discloses a material acquisition transaction under Item 8.01 (Other Events). Cycurion entered into an Agreement and Plan of Merger on May 7, 2026 with Halo Privacy, Inc. and havenX, Inc., with a scheduled closing by July 31, 2026 (the "Outside Date"). The disclosure indicates that as of the filing date (July 29, 2026), the transaction is unlikely to close due to a Key Employee's refusal to commence employment post-closing and Halo/havenX's failure to deliver required audited financial statements and closing deliverables. This represents a material M&A event in jeopardy, which would significantly affect investor assessment of the registrant's strategic position and financial prospects.
View raw filing on EDGAR →The filing discloses completion of a disposition of a wholly owned subsidiary (Mahaotiaodong Information Technology Company) on July 9, 2026, pursuant to an Equity Transfer Agreement signed July 1, 2026. This is a material change of control event involving sale of 100% of a subsidiary's shares, classifiable as a completed disposition under Item 1.02 / 2.01 of the 8-K taxonomy (or equivalent 6-K disclosure). The nominal consideration (US$100) does not diminish materiality of divesting an entire subsidiary.
View raw filing on EDGAR →The filing discloses entry into a definitive merger agreement on July 29, 2026, under which MiMedx Group, Inc. will acquire all outstanding shares of Sanara MedTech Inc. in a cash and stock transaction valued at $35 per share with a total enterprise value of approximately $350 million. Item 1.01 explicitly covers "Entry into a Material Definitive Agreement," and the merger consideration ($33 cash + 0.4735 MDXG shares per SMTI share) and strategic rationale (expansion of surgical footprint, nearly doubling surgical revenue, $20M+ cost synergies) clearly constitute a material acquisition transaction.
View raw filing on EDGAR →The filing discloses merger activity ("the Mergers") with stock consideration to be issued to counterparties, explicitly referencing Item 1.01 (entry into material agreements/M&A) and Item 3.02 (unregistered equity issuances). The securities are being issued in reliance on Section 4(a)(2) exemption, indicating a private transaction. This is a material acquisition or merger event.
View raw filing on EDGAR →Coursera entered into a Series A Preferred Stock Purchase Agreement with LearnVector Inc., acquiring a 33.33% ownership stake for $100 million. The transaction closed simultaneously with agreement execution and includes customary representations, warranties, and covenants typical of M&A activity.
View raw filing on EDGAR →SEACOR Marine's Board initiated a formal review of strategic alternatives to maximize shareholder value, which may include a sale of the Company, merger, other business combinations, sale of assets, or other transactions. No timetable has been established and no definitive agreement has been reached.
View raw filing on EDGAR →Splash Beverage entered into an addendum on July 28, 2026 that materially expands its exclusive global license agreement for CannEpil® to include veterinary therapeutic applications, creating a second FDA-regulated pharmaceutical development program. This expansion significantly broadens the Company's intellectual property rights and commercial opportunity in companion-animal markets valued at $2.6–$3.8 billion (pain management) and $900 million–$1.7 billion (oncology), and the Company is finalizing a joint venture with an established cannabinoid pharmaceutical company to lead the veterinary development program.
View raw filing on EDGAR →The filing discloses a pending merger between Skyworks and Qorvo, with the announcement of the expected executive leadership team for the combined company "effective upon the successful completion of the pending transaction." While the merger itself was previously announced, this Item 8.01 disclosure provides a material update on transaction progress and post-close governance structure, including the appointment of Phil Brace as CEO and eight named executives to senior leadership roles. The disclosure references the Form S-4 registration statement (File No. 333-291947) declared effective December 23, 2025, confirming the transaction is in advanced stages toward completion.
View raw filing on EDGAR →The disclosure reports shareholder approval of Ingredion's recommended all-cash acquisition of Tate & Lyle PLC, announced June 8, 2026. Tate & Lyle shareholders voted on July 28, 2026 to approve the scheme of arrangement under UK law, satisfying a material condition to completion. This is a significant M&A milestone—shareholder approval of a cross-border acquisition—that materially affects the registrant's strategic direction and financial position.
View raw filing on EDGAR →Energy Fuels Inc. entered into definitive agreements to acquire 100% of Australian Strategic Materials Limited (ASM) via a scheme of arrangement and 100% of Vacuumschmelze GmbH & Co. KG (VAC) from Ara Partners, with a conditional $725 million financing commitment from the U.S. Office of Strategic Capital. Shareholder approval is scheduled for August 12, 2026.
View raw filing on EDGAR →ConnectM Technology Solutions acquired 60% of Blue Ribbon Ice (6,000 shares) on July 1, 2026, in exchange for 58,824 shares of ConnectM common stock and $250,000 cash. The acquisition is a strategic tuck-in that expands ConnectM's AI-Powered Logistics platform into commercial HVAC and field services, adding a new customer base and generating new data streams for the company's AI engine.
View raw filing on EDGAR →Yarrow Bioscience completed its merger with VYNE Therapeutics on July 27–28, 2026, with the combined company operating as Yarrow Bioscience and trading on Nasdaq under ticker 'YARW.' The transaction included a 0.7171 share conversion ratio, a 1-for-50 reverse stock split of VYNE common stock, an increase in authorized shares from 150M to 300M, and concurrent $200 million private placement financing.
View raw filing on EDGAR →Standard BioTools entered into multiple material M&A transactions: (1) a Termination, Waiver and Release Agreement with Illumina for $30 million cash to waive earnout and royalty obligations from the SomaLogic acquisition, (2) a Share and Asset Purchase Agreement to sell its mass cytometry business (CyTOF and Hyperion product lines) to Multiplex Bio for up to $10 million, and (3) a pending merger with Treeline Biosciences (Form S-4 filed July 20, 2026; HSR early termination received July 21, 2026). These transactions materially affect the company's asset base, cash position, and business structure.
View raw filing on EDGAR →TOP Ships announced the sale of 100% of shares in a special purpose vehicle (SPV) holding a shipbuilding contract for a 47,499 dwt MR tanker to related party Rubico Inc. for approximately $6.5 million, expected to close by September 30, 2026. This constitutes a material disposition of an asset (the newbuilding vessel contract) and was approved by an independent special committee with a fairness opinion, meeting the criteria for ma_activity disclosure under Item 1.02 or 2.01 of Form 8-K equivalent standards.
View raw filing on EDGAR →ReNew Energy announces receipt of a best and final non-binding proposal from Canada Pension Plan Investment Board and founder Sumant Sinha to acquire all shares not already owned by the Consortium for US$7.02 per share via a UK scheme of arrangement. This represents a material acquisition/change of control transaction at a 12.5% premium to the pre-announcement closing price, with active negotiations ongoing through a Special Committee. The disclosure of a binding acquisition proposal is a core M&A event material to investors.
View raw filing on EDGAR →The disclosure addresses a potential acquisition of Lotte Insurance by Shinhan Financial Group. Although no decision has been made, the company is actively reviewing measures to enhance competitiveness through this potential M&A activity. The explicit mention of "potential acquisition" and commitment to disclose when matters are determined signals material M&A activity under consideration, even in its preliminary stage.
View raw filing on EDGAR →Core University Living REIT completed the acquisition of a portfolio of four student housing properties for $303.5 million on July 22, 2026, through wholly owned subsidiaries, representing a significant capital deployment and material M&A activity.
View raw filing on EDGAR →AT&T closed its acquisition of wireless spectrum licenses from EchoStar for approximately $23 billion, adding significant spectrum assets (approximately 50 MHz across low-band and mid-band frequencies) nationwide. The company financed the transaction by drawing $14.5 billion ($11.5 billion on a two-year term loan facility plus $3.0 billion on a 364-day term loan facility) from its $17.5 billion Delayed Draw Term Loan Credit Agreement.
View raw filing on EDGAR →IonQ announced on July 28, 2026, that it received final regulatory approval to complete its acquisition of SkyWater Technology, a material M&A transaction previously disclosed on January 25, 2026. The filing discloses the anticipated closing date of July 31, 2026, and describes the two-step merger structure whereby SkyWater will become a wholly owned subsidiary of IonQ. This is a material acquisition that would significantly affect investor assessment of IonQ's business, strategy, and financial position.
View raw filing on EDGAR →SkyWater disclosed receipt of final regulatory approval to consummate its acquisition by IonQ, with closing anticipated for July 31, 2026. The filing describes a two-step merger structure whereby SkyWater will become a wholly owned subsidiary of IonQ. This is a material change of control transaction that would significantly affect a reasonable investor's assessment of SkyWater's future as an independent company.
View raw filing on EDGAR →The Formation Agreement establishes a new Hong Kong-incorporated entity ("Maison AI Limited") in which Maison Solutions' subsidiary AZLL will hold ~90% ownership and contribute software valued at US$2,000,000, while external parties contribute US$220,000 in cash. This constitutes entry into a material definitive agreement for formation of a joint venture or controlled subsidiary with significant asset contribution and equity structure, fitting the M&A activity category under Item 1.01.
View raw filing on EDGAR →T1 Energy acquired intellectual property and related assets from Evervolt Green Energy for $135 million total consideration ($2 million option premium plus $133 million purchase price). The filing discloses entry into a material definitive IP Purchase Agreement (Item 1.01), completion of the acquisition (Item 2.02), and termination of existing license agreements (Item 1.02). The transaction involves acquisition of foundational solar patents and TOPCon technology previously licensed, representing a material acquisition of assets that eliminates future royalty obligations and advances the company's strategic position as a vertically integrated solar manufacturer.
View raw filing on EDGAR →The Company entered into a Share Purchase Agreement on July 27, 2026, to sell all issued and outstanding shares of Australian Oilseeds Investments Pty Ltd and its subsidiaries, which collectively carry on the Company's oilseed crushing and edible oils business. This constitutes a material disposition of a significant operating business segment, meeting the definition of ma_activity under Item 1.02 (Unregistered Sales of Equity Securities) or Item 2.01 (Completion of Acquisition or Disposition of Assets).
View raw filing on EDGAR →Ellomay's Luxembourg subsidiary signed an agreement to acquire 100% of a project company holding a 51.75 MW / 207 MWh battery energy storage system in northern Italy. This is a material acquisition of a ready-to-build energy asset, representing Ellomay's entry into the Italian battery storage market. The transaction is subject to conditions precedent with a deadline of end-2027, consistent with Item 1.01 (Material Agreements) or Item 2.01 (Completion of Acquisition or Disposition) disclosure requirements.
View raw filing on EDGAR →Cadiz's subsidiary Fenner Gap entered into two material definitive construction agreements (CMAR agreements) with W.M. Lyles Co. and Mike Bubalo Construction Co. on July 27, 2026, establishing aggregate guaranteed maximum prices of approximately $273.8 million for pipeline replacement and pump-station construction required to place the Northern Pipeline into service. While these are construction contracts rather than traditional M&A, they represent material definitive agreements that are foundational to the company's infrastructure project development and would materially affect investor assessment of project execution and capital deployment.
View raw filing on EDGAR →Market Technology Acquisition Corp consummated its IPO on July 27, 2026, issuing 20.5 million units for $205 million in gross proceeds and entering into multiple material definitive agreements (Underwriting Agreement, Warrant Agreement, Investment Management Trust Agreement, Registration Rights Agreement, and Private Placement Units Purchase Agreements) foundational to the SPAC structure and its stated purpose of effecting a business combination.
View raw filing on EDGAR →Westin Acquisition Corp entered into a definitive Business Combination Agreement with First Choice Healthcare Solutions, Inc., valued at approximately $650 million in equity value. The transaction contemplates domestication of the SPAC from Cayman Islands to Nevada followed by a merger creating a publicly traded healthcare company, with expected closing in Q4 2026.
View raw filing on EDGAR →Rising Dragon Acquisition Corp. entered into a material definitive agreement, likely a business combination or acquisition agreement, and concurrently created direct financial obligations through the issuance of unsecured promissory notes totaling approximately $111,274 to its sponsor and a merger counterparty designee.
View raw filing on EDGAR →This news release announces that the Supreme Court of British Columbia has granted the final order approving Orla Mining's business combination with Equinox Gold Corp., whereby Equinox Gold will acquire all issued and outstanding common shares of Orla. The Arrangement is expected to close on or about July 31, 2026, with Orla shares subsequently delisting from the TSX and NYSE American. This is a material acquisition/change of control event that fundamentally alters the registrant's corporate structure and shareholder base.
View raw filing on EDGAR →The filing discloses that Luxfer Holdings PLC has agreed to be acquired for $17.37 per share in an all-cash transaction, announced on July 28, 2026. This constitutes entry into a material acquisition/change of control transaction, which is a core M&A event requiring 8-K disclosure under Item 1.01 or 2.01. The transaction is material to investors as it represents a fundamental change in the company's status and ownership.
View raw filing on EDGAR →GMEX Robotics has entered into a definitive share purchase agreement to acquire an initial 30% equity interest in MediaMeta.Ai with an option to acquire additional shares potentially leading to a controlling interest. The transaction includes $52.6 million in expected revenues over five years, an exclusive perpetual technology license, and is explicitly described as a "strategic acquisition." This is a material M&A activity requiring disclosure under Item 1.01 or 2.01 equivalent for foreign private issuers.
View raw filing on EDGAR →The filing discloses execution of a definitive Business Combination Agreement dated July 22, 2026, between Westin Acquisition Corp. (SPAC), First Choice Healthcare Solutions, Inc., and First Choice Acquisition Corp. (Merger Sub). The transaction values First Choice at approximately $650 million enterprise value and is expected to result in a publicly traded combined company on Nasdaq. This is a material M&A event involving a change of control through a SPAC merger.
View raw filing on EDGAR →The filing discloses termination of the Exclusive License and Supply Agreement with VetStem, effective July 24, 2026, under Item 1.02 (Termination of a Material Definitive Agreement). The agreement involved reversion of exclusive rights, transfer of PrecisePRP® inventory, and mutual release of claims. While technically a termination rather than a new transaction, this represents a material change in the Company's commercial relationships and product portfolio structure, requiring $75,000 in settlement payments and affecting the Company's ability to commercialize the PrecisePRP® product line—a material operational and financial event.
View raw filing on EDGAR →The press release announces that MacKenzie Realty Capital has completed a successful tender offer to purchase over $1,000,000 in shares of National Healthcare Properties, Inc. at $7.27 per share, with the company increasing its purchase commitment from 150,000 to 300,000 shares. This represents a material acquisition activity involving the purchase of a significant equity stake in another company, financed by a new loan agreement. The transaction is material to investors as it represents a strategic capital deployment and creates an unrealized gain of over $1,200,000.
View raw filing on EDGAR →Kinetic Seas entered into a Third Addendum to its Licensing Agreement with Sagtec Global Limited on July 7, 2026, which modified material commercial terms including the return of 2,000,000 consideration shares, elimination of right of first refusal, and establishment of additional commercial arrangements. While this is technically an amendment to an existing agreement rather than a new M&A transaction, the modification of commercial arrangements and share transfer constitute a material modification to the parties' relationship that affects the registrant's capital structure and contractual obligations.
View raw filing on EDGAR →VersaBank announced a special shareholder meeting scheduled for September 16, 2026, to vote on a proposed reorganization that will realign its corporate structure to a standard U.S. bank framework. The reorganization involves creating Versa Bancorp, a new Delaware corporation, as the direct holding company of VersaBank and VersaBank USA National Association, with Versa Bancorp succeeding VersaBank as the publicly traded company. This constitutes a material change of control and corporate restructuring requiring shareholder approval and regulatory approvals from the Canadian Minister of Finance and the U.S. Federal Reserve Board.
View raw filing on EDGAR →Leonardo DRS announced entry into a definitive agreement to acquire Raft LLC in an all-cash transaction valued at $450 million. The press release explicitly states the company "has entered into a definitive agreement to acquire Raft LLC" and describes the strategic rationale, expected timing (Q4 2026), financing approach, and anticipated financial benefits (accretion and ~$50M tax benefit). This is a material acquisition that would significantly affect investor assessment of the company's strategy and financial position.
View raw filing on EDGAR →PLP Canada, a subsidiary of Preformed Line Products Company, acquired a facility and related land for approximately CAD 23.5 million ($16.7 million) on July 21, 2026. Although disclosed under Item 8.01 (Other Events) rather than the typical Item 1.01 or 2.01, this constitutes a material acquisition of a property asset intended to expand manufacturing capacity and support growth. The transaction size and strategic purpose (capacity expansion) make it material to investors.
View raw filing on EDGAR →SQM and Wesfarmers announced a final investment decision to expand the Mt Holland lithium project through their joint venture Covalent Lithium. The expansion involves significant capital expenditure (US$450–500 million for SQM's share), doubling spodumene concentrate production capacity from 380,000 to 760,000 tonnes per year, and construction commencing in H2 2027. This constitutes a material capital commitment and operational expansion that would affect a reasonable investor's assessment of the registrant's growth strategy and capital allocation.
View raw filing on EDGAR →This Item 8.01 discloses material updates to an ongoing merger transaction involving Katapult, Aaron's, and CCFI. The filing describes the merger structure, the stockholder meeting scheduled for August 6, 2026, and supplemental disclosures addressing litigation and stockholder demand letters challenging the proxy statement. The core event is the continuation and amendment of a material acquisition/merger, with the special meeting imminent. While litigation is mentioned, the primary disclosure focus is on the merger transaction itself and corrective disclosures related to it.
View raw filing on EDGAR →Knox Lane completed its acquisition of Cross Country Healthcare, Inc., resulting in a material change of control. The company transitioned from public to private ownership and became a wholly-owned subsidiary of Knox Lane Parent, with the locums division separately acquired by an affiliate.
View raw filing on EDGAR →This is a definitive announcement of argenx's acquisition of Forte Biosciences for $77 per share in cash, representing approximately $2.2 billion in total equity value. The press release explicitly states that "the companies have entered into a definitive agreement" and describes the transaction structure (tender offer followed by merger), closing conditions, and expected timing (Q3 2026). This is a material acquisition that would significantly affect a reasonable investor's assessment of argenx's strategy, pipeline, and capital allocation.
View raw filing on EDGAR →